Science Explorer Back to mapMap
Discussion
Researcher · Noxxon Pharma (Germany) · Germany

Dirk Eulberg

Dirk Eulberg publishes mostly in Oncology, Molecular Biology and Immunology, on topics such as Chemokine receptors and signaling, Cancer Immunotherapy and Biomarkers and Immune cells in cancer.

ORCID 0000-0003-4447-1413 OpenAlex
World rank
#254,420
of 7,710,434 ranked researchers
Rank in Germany
#12,847
of 364,343
Works
64
Citations
4.8k
Citations per work
74.5
h-index
33
i10-index 41Top 9.4% in Oncology
Dirk Eulberg

What does Dirk Eulberg research?

Dirk Eulberg's work is mostly in Medicine (34%), Biochemistry, Genetics and Molecular Biology (24%), Immunology and Microbiology (11%).

Life Sciences: 22 works · 34.5% of their workBiochemistry, Genetics and Molecular Biology: 15 works · 23.9% of their workMolecular Biology: 13 works · 20.6% of their workGenetics: 2 works · 3.3% of their workImmunology and Microbiology: 7 works · 10.6% of their workImmunology: 7 works · 10.6% of their workHealth Sciences: 22 works · 34.4% of their workMedicine: 22 works · 34.4% of their workOncology: 14 works · 22.2% of their workHepatology: 5 works · 7.2% of their workNephrology: 3 works · 5.0% of their workEverything else: 20 works · 31.1% of their workTHEIR WORKDirk Eulberg64works
Life Sciences34%Health Sciences34%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1523.9%
    2. Immunology and Microbiology710.6%
    1. Medicine2234.4%
  3. Everything else2031.1%
  1. 1Oncology22% of their works
  2. 2Molecular Biology21% of their works
  3. 3Immunology11% of their works
  4. 4Hepatology7% of their works
  5. 5Nephrology5% of their works
  6. 6Genetics3% of their works

Research topics

Which keywords describe Dirk Eulberg's research?

The keywords of their largest research topics: Inflammation, Cancer Metastasis, Chemokine Receptors, Immune Checkpoint Blockade, PD-1 and PD-L1, Activation, Macrophage and Cetuximab.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Inflammation252 topics
  2. Cancer Metastasis171 topic
  3. Chemokine Receptors171 topic
  4. Immune Checkpoint Blockade131 topic
  5. PD-1 and PD-L1131 topic
  6. Activation81 topic
  7. Macrophage81 topic
  8. Cetuximab71 topic
  9. KRAS Mutations71 topic
  10. DNA nanotechnology61 topic
  11. Self-Assembly61 topic
  12. Genome-Scale Models51 topic
  13. Hepatocellular Carcinoma51 topic
  14. Liver Cancer51 topic
  15. Metabolic Engineering51 topic
  16. RNA Interference51 topic
  17. siRNA Delivery51 topic

Where does Dirk Eulberg work?

Dirk Eulberg's main affiliation in the publication record is Noxxon Pharma (Germany), Germany.

How many publications and citations does Dirk Eulberg have?

OpenAlex counts 64 works and 4,771 citations for Dirk Eulberg, an h-index of 33, ranking #254,420 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Dirk Eulberg. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.